A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Official record

Identifier

NCT05428176

Recruiting locations

country

United States

Interventions studied

Best PracticeInternet-Based InterventionQuality-of-Life AssessmentQuestionnaire Administration

Lead sponsor

City of Hope Medical Center

Target enrolment

332 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Active, not recruiting

First posted

Jun 22, 2022

Last updated on the registry

Aug 14, 2026

Age

6 Years

Sex

ALL

Study contact

No public contact is listed on the official record.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Documented informed consent of the participant and/or legally authorized representative

  * Assent, when appropriate, will be obtained per institutional guidelines
* Primary participating parent/caregiver is English- or Spanish-speaking (any race/ethnicity)
* Child is aged 6-12 years (yr.) (for the website usability pre-study, child is age 8 - 12 yrs.)
* Child understands English (but can be bilingual)
* Child treated for acute leukemia (e.g., acute lymphoblastic leukemia, acute myelogenous leukemia) or lymphoblastic lymphoma
* Child is in cancer remission and has completed cancer therapies, including maintenance treatment
* Primary participating parent/caregiver has daily contact with the child
* Child is enrolled in school

Exclusion Criteria:

* Recent or current participation in a behavioral intervention study with a similar focus
* History of major psychiatric condition (e.g., psychosis) in parent or child
* Severe neurodevelopmental disorder in the child (e.g., down syndrome, intellectual disability)
* Child has previously used the IXL online learning program extensively and unwilling to regularly use it again
* Any other condition that would, in the investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures
* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)

Indexed under

Lymphoma